APA (7th ed.) Citation

Santra, M., Geary, M. L., Rubin, E., Hsu, M. Y. S., Funderburgh, M. L., Chandran, C., . . . Yam, G. H. (2024). Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring. Stem Cell Research & Therapy, 15(1), 1. https://doi.org/10.1186/s13287-023-03626-8

Chicago Style (17th ed.) Citation

Santra, Mithun, et al. "Good Manufacturing Practice Production of Human Corneal Limbus-derived Stromal Stem Cells and in Vitro Quality Screening for Therapeutic Inhibition of Corneal Scarring." Stem Cell Research & Therapy 15, no. 1 (2024): 1. https://doi.org/10.1186/s13287-023-03626-8.

MLA (9th ed.) Citation

Santra, Mithun, et al. "Good Manufacturing Practice Production of Human Corneal Limbus-derived Stromal Stem Cells and in Vitro Quality Screening for Therapeutic Inhibition of Corneal Scarring." Stem Cell Research & Therapy, vol. 15, no. 1, 2024, p. 1, https://doi.org/10.1186/s13287-023-03626-8.